Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Encycle Therapeutics

Encycle Therapeutics
2012 FOUNDED
M&A STATUS
1-10 EMPLOYEES
M&A LATEST DEAL TYPE
$80M LATEST DEAL AMOUNT
Description

Developer of drugs designed to exploit a novel synthetic method to generate drug-like cyclic peptides. The company's drugs are generated by several scaffolds that are membrane permeable and orally bioavailable products, such as nacellins which are ideal for targeting protein-protein interactions, enabling patients to get cured from inflammatory bowel disease and other inflammatory disorders.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
Primary Office
  • 101 College Street
  • Suite 314
  • Toronto, Ontario M5G 1L7
  • Canada

+1 (647) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Encycle Therapeutics’s full profile, request a free trial.

Encycle Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 23-Oct-2019 $80M 00.000 0000 Completed Generating Revenue
5. Corporate 01-Nov-2017 00000 00.000 Completed Generating Revenue
4. Early Stage VC 30-Sep-2015 00.000 00.000 Completed Startup
3. Early Stage VC 16-Jun-2015 00000 00.000 Completed Startup
2. Grant 17-Nov-2014 $2.5M Completed Startup
1. Early Stage VC 11-Nov-2014 $2.5M $2.5M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Encycle Therapeutics Competitors (22)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ImmusanT Venture Capital-Backed Cambridge, MA 00 000.00 00000000000 000.00
000000 00000000000 Formerly VC-backed Boston, MA 00 00000 00000000 00000
0000000 0000000000 Formerly VC-backed Watertown, MA 00 00000 000000000 00000
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
00000000 000000000 Venture Capital-Backed Vienna, Austria 00.000 0000000000 00.000
To view this company’s complete list of competitors, request access »

Encycle Therapeutics Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Accel-Rx Accelerator/Incubator Minority 000 0000 000000 0
Business Development Bank of Canada Venture Capital Minority 000 0000 000000 0
CQDM Government Minority 000 0000 000000 0
MaRS Investment Accelerator Fund Venture Capital Minority 000 0000 000000 0
Merck & Co. Corporation 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Encycle Therapeutics Executive Team (3)

Name Title Board
Seat
Contact
Info
Jeffrey Coull Ph.D Chief Executive Officer & President

2 Former Executives

You’re viewing 1 of 3 executives. Get the full list »